Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212172 · ClinicalTrials.gov registry record · Phase 3
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
A Phase 3 study of Hypertrichosis, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01212172 is a Phase 3 study of Hypertrichosis that has completed, run by University of California, Irvine. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01212172, a Phase 3 study of Hypertrichosis, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal is determine the subject's perspective on the treatment including tolerability and effectiveness.
Conditions Studied
Interventions
- DEVICE Soprano/SHR
- DEVICE LightSheer
Study Locations (1)
California
- Department of Dermatology Clinical Research - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01212172
The ClinicalTrials.gov registry entry for NCT01212172 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertrichosis appearing as the primary indexed condition, and to 2 interventions - of which Soprano/SHR is the first listed.
NCT01212172 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01212172 about?
NCT01212172 is a clinical study titled "Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction". The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal...
What is the current status of trial NCT01212172?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2010-09. Estimated completion is 2013-09.
What conditions does trial NCT01212172 study?
This clinical trial studies the following conditions: Hypertrichosis.
What interventions are being tested in trial NCT01212172?
The interventions under investigation include: Soprano/SHR (DEVICE), LightSheer (DEVICE).
Who is sponsoring clinical trial NCT01212172?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01212172 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrichosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.